Abstract	O
.	O

The	O
COVID	O
-	O
19	O
pandemic	O
is	O
showing	O
an	O
exponential	O
growth	O
,	O
mandating	O
an	O
urgent	O
need	O
to	O
develop	O
an	O
effective	O
treatment	O
.	O

Indeed	O
,	O
to	O
date	O
,	O
a	O
well	O
-	O
established	O
therapy	O
is	O
still	O
lacking	O
.	O

We	O
aimed	O
to	O
evaluate	O
the	O
safety	O
and	O
efficacy	O
of	O
hydroxychloroquine	O
(	O
HCQ	O
)	O
added	O
to	O
standard	O
care	O
in	O
patients	O
with	O
COVID	O
-	O
19	O
.	O

This	O
was	O
a	O
multicenter	O
,	O
randomized	O
controlled	O
trial	O
conducted	O
at	O
three	O
major	O
university	O
hospitals	O
in	O
Egypt	O
.	O

One	O
hundred	O
ninety	O
-	O
four	O
patients	O
with	O
confirmed	O
diagnosis	O
of	O
COVID	O
-	O
19	O
were	O
included	O
in	O
the	O
study	O
after	O
signing	O
informed	O
consent	O
.	O

They	O
were	O
equally	O
randomized	O
into	O
two	O
arms	O
:	O
97	O
patients	O
administrated	O
HCQ	O
plus	O
standard	O
care	O
(	O
HCQ	O
group	O
)	O
and	O
97	O
patients	O
administered	O
only	O
standard	O
care	O
as	O
a	O
control	O
arm	O
(	O
control	O
group	O
)	O
.	O

The	O
primary	O
endpoints	O
were	O
recovery	B-PrimaryOutcome
within	B-TimeFrame
28	I-TimeFrame
days	I-TimeFrame
,	O
need	B-PrimaryOutcome
for	I-PrimaryOutcome
mechanical	I-PrimaryOutcome
ventilation	I-PrimaryOutcome
,	O
or	O
death	B-PrimaryOutcome
.	O

The	O
two	O
groups	O
were	O
matched	O
for	O
age	O
and	O
gender	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
them	O
regarding	O
any	O
of	O
the	O
baseline	O
characteristics	O
or	O
laboratory	O
parameters	O
.	O

Four	O
patients	O
(	O
4	O
.	O
1	O
%	O
)	O
in	O
the	O
HCQ	O
group	O
and	O
5	O
(	O
5	O
.	O
2	O
%	O
)	O
patients	O
in	O
the	O
control	O
group	O
needed	O
mechanical	O
ventilation	O
(	O
P	O
=	O
0	O
.	O
75	O
)	O
.	O

The	O
overall	O
mortality	O
did	O
not	O
differ	O
between	O
the	O
two	O
groups	O
,	O
as	O
six	O
patients	O
(	O
6	O
.	O
2	O
%	O
)	O
died	O
in	O
the	O
HCQ	O
group	O
and	O
5	O
(	O
5	O
.	O
2	O
%	O
)	O
died	O
in	O
the	O
control	O
group	O
(	O
P	O
=	O
0	O
.	O
77	O
)	O
.	O

Univariate	O
logistic	O
regression	O
analysis	O
showed	O
that	O
HCQ	O
treatment	O
was	O
not	O
significantly	O
associated	O
with	O
decreased	O
mortality	O
in	O
COVID	O
-	O
19	O
patients	O
.	O

So	O
,	O
adding	O
HCQ	O
to	O
standard	O
care	O
did	O
not	O
add	O
significant	O
benefit	O
,	O
did	O
not	O
decrease	O
the	O
need	O
for	O
ventilation	O
,	O
and	O
did	O
not	O
reduce	O
mortality	O
rates	O
in	O
COVID	O
-	O
19	O
patients	O

